InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ghmm post# 540

Thursday, 02/11/2010 3:03:31 PM

Thursday, February 11, 2010 3:03:31 PM

Post# of 3990
GENZ/eliglustat tartrate (GENZ-112638)- its efficacy is even more robust than I would have thought. If no surprises occur in phase III and switchover trial, it will be a game changer, imo. Btw, I believe PLX is also looking at bone MRI, but it's too early to tell if data are better than Cerezyme's historical studies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News